Creative Commons source reading · Functional and stereotactic neurosurgery
Prolonged life of human acute hippocampal slices from temporal lobe epilepsy surgery.
J Wickham; N G Brödjegård; R Vighagen; L H Pinborg; J Bengzon; D P D Woldbye; M Kokaia; M Andersson
Originally published in Scientific reports · 2018-03-07
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Resected hippocampal tissue from patients with drug-resistant epilepsy presents a unique possibility to test novel treatment strategies directly in target tissue. The post-resection time for testing and analysis however is normally limited. Acute tissue slices allow for electrophysiological recordings typically up to 12 hours. To enable longer time to test novel treatment strategies such as, e.g., gene-therapy, we developed a method for keeping acute human brain slices viable over a longer period. Our protocol keeps neurons viable well up to 48 hours. Using a dual-flow chamber, which allows for microscopic visualisation of individual neurons with a submerged objective for whole-cell patch-clamp recordings, we report stable electrophysiological properties, such as action potential amplitude and threshold during this time. We also demonstrate that epileptiform activity, monitored by individual dentate granule whole-cell recordings, can be consistently induced in these slices, underlying the usefulness of this methodology for testing and/or validating novel treatment strategies for epilepsy.
Discussion
Here we present a method for human brain slice incubation where human hippocampal slices are viable and functionally preserved for 48 hours after resection from patients with drug-resistant temporal lobe epilepsy. We provide evidence that this unique tissue could be used for electrophysiological experiments for a prolonged period, therefore enabling increased number of experiments to be carried out from the same resection surgery, as well as allowing for broader experimental approaches, such as fast-expressing viral vector based gene therapy strategy validations.
Editorial reading guide
- How were patients or cases selected, and what did the authors use as a comparator?
- Which outcomes, complications and follow-up intervals determine how far the findings apply?
